Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of 1life Healthcare Inc (ONEM) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of 1life Healthcare Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1404123.
Total stock buying since 2020: $0.
Total stock sales since 2020: $729,587,199.
Total stock option exercises since 2020: $56,167,583.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2023 | 0 | $0 | 21,878 | $335,736 | 46,008 | $0 |
2022 | 0 | $0 | 7,978,442 | $136,436,987 | 7,656,113 | $38,765,625 |
2021 | 0 | $0 | 1,666,984 | $72,011,734 | 1,738,484 | $8,298,152 |
2020 | 0 | $0 | 16,605,702 | $520,802,742 | 2,078,845 | $9,103,806 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2023-02 | 0 | $0 | 21,878 | $335,736 | 46,008 | $0 |
2022-12 | 0 | $0 | 6,316 | $105,635 | 0 | $0 |
2022-11 | 0 | $0 | 28,016 | $467,720 | 42,113 | $208,667 |
2022-10 | 0 | $0 | 7,942,294 | $135,842,290 | 7,569,548 | $38,556,958 |
2022-09 | 0 | $0 | 0 | $0 | 9,903 | $0 |
2022-08 | 0 | $0 | 394 | $6,753 | 1,080 | $0 |
2022-06 | 0 | $0 | 0 | $0 | 29,471 | $0 |
2022-02 | 0 | $0 | 1,422 | $14,589 | 3,998 | $0 |
2021-12 | 0 | $0 | 0 | $0 | 99,748 | $399,989 |
2021-09 | 0 | $0 | 2,778 | $68,672 | 0 | $0 |
2021-08 | 0 | $0 | 2,778 | $64,996 | 0 | $0 |
2021-07 | 0 | $0 | 2,778 | $73,183 | 0 | $0 |
2021-06 | 0 | $0 | 8,334 | $292,223 | 5,551 | $32,695 |
2021-05 | 0 | $0 | 5,556 | $191,409 | 0 | $0 |
2021-04 | 0 | $0 | 84,874 | $3,481,360 | 76,540 | $528,770 |
2021-03 | 0 | $0 | 76,666 | $3,321,567 | 109,398 | $577,991 |
2021-02 | 0 | $0 | 80,768 | $4,445,855 | 85,044 | $457,906 |
2021-01 | 0 | $0 | 1,402,452 | $60,072,469 | 1,362,203 | $6,300,801 |
2020-12 | 0 | $0 | 134,590 | $5,112,286 | 176,345 | $995,246 |
2020-11 | 0 | $0 | 7,403,556 | $247,057,944 | 398,000 | $1,664,150 |
2020-10 | 0 | $0 | 56,556 | $1,718,123 | 88,500 | $456,015 |
2020-09 | 0 | $0 | 361,222 | $10,062,015 | 361,222 | $1,586,365 |
2020-08 | 0 | $0 | 1,104,778 | $32,313,174 | 1,054,778 | $4,402,030 |
2020-06 | 0 | $0 | 7,545,000 | $224,539,200 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-02-17 | Mango Lisa A (General Counsel and Secretary) | Sale | 6,150 | 15.32 | 94,218 |
2023-02-16 | Agarwal Vikas (Chief Accounting Officer) | Sale | 2,117 | 15.36 | 32,508 |
2023-02-16 | Thaler Bjorn B (Chief Financial Officer) | Sale | 6,015 | 15.36 | 92,366 |
2023-02-16 | Mango Lisa A (General Counsel and Secretary) | Sale | 7,596 | 15.36 | 116,644 |
2023-02-15 | Agarwal Vikas (Chief Accounting Officer) | Option Ex | 5,132 | .00 | 0 |
2023-02-15 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 13,301 | .00 | 0 |
2023-02-15 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 13,829 | .00 | 0 |
2023-02-15 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 13,746 | .00 | 0 |
2022-12-20 | Thaler Bjorn B (Chief Financial Officer) | Sale | 6,116 | 16.72 | 102,235 |
2022-12-01 | Thaler Bjorn B (Chief Financial Officer) | Sale | 200 | 17.00 | 3,400 |
2022-11-21 | Mango Lisa A (General Counsel and Secretary) | Sale | 8,204 | 16.58 | 136,038 |
2022-11-21 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 8,204 | 11.52 | 94,468 |
2022-11-17 | Thaler Bjorn B (Chief Financial Officer) | Sale | 761 | 16.70 | 12,708 |
2022-11-17 | Mango Lisa A (General Counsel and Secretary) | Sale | 4,312 | 16.71 | 72,036 |
2022-11-16 | Thaler Bjorn B (Chief Financial Officer) | Sale | 3,935 | 16.81 | 66,143 |
2022-11-16 | Mango Lisa A (General Counsel and Secretary) | Sale | 4,230 | 16.82 | 71,148 |
2022-11-15 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 8,542 | .00 | 0 |
2022-11-15 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 10,251 | .00 | 0 |
2022-11-15 | Mango Lisa A (General Counsel and Secretary) | Sale | 2,472 | 16.84 | 41,628 |
2022-11-15 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 11,014 | 6.08 | 66,965 |
2022-10-24 | Diamond Andrew S (Chief Medical Officer) | Sale | 293,185 | 17.08 | 5,007,599 |
2022-10-24 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 184,211 | 8.65 | 1,594,346 |
2022-10-21 | Mango Lisa A (General Counsel and Secretary) | Sale | 1,602 | 17.08 | 27,363 |
2022-10-21 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 1,602 | 11.56 | 18,519 |
2022-10-19 | Mango Lisa A (General Counsel and Secretary) | Sale | 2,500 | 17.06 | 42,642 |
2022-10-19 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 2,500 | 11.47 | 28,675 |
2022-10-17 | Mango Lisa A (General Counsel and Secretary) | Sale | 2,472 | 17.06 | 42,169 |
2022-10-17 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 2,472 | 12.16 | 30,059 |
2022-10-12 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 12,610 | 7.93 | 99,997 |
2022-10-07 | Rubin Amir Dan (Chair, CEO and President) | Sale | 1,371,117 | 17.03 | 23,348,751 |
2022-10-07 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 1,371,117 | 7.79 | 10,674,145 |
2022-10-06 | Rubin Amir Dan (Chair, CEO and President) | Sale | 1,825,289 | 17.08 | 31,181,411 |
2022-10-06 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 1,825,289 | 4.01 | 7,319,408 |
2022-10-05 | Rubin Amir Dan (Chair, CEO and President) | Sale | 2,123,402 | 17.09 | 36,297,433 |
2022-10-05 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 2,123,402 | 4.01 | 8,514,842 |
2022-10-04 | Thaler Bjorn B (Chief Financial Officer) | Sale | 325,575 | 17.18 | 5,593,704 |
2022-10-04 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 298,570 | 7.93 | 2,367,660 |
2022-10-04 | Mango Lisa A (General Counsel and Secretary) | Sale | 133,838 | 17.18 | 2,298,801 |
2022-10-04 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 133,838 | 10.74 | 1,437,420 |
2022-10-04 | Rubin Amir Dan (Chair, CEO and President) | Sale | 1,863,314 | 17.18 | 32,002,417 |
2022-10-04 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 1,613,937 | 4.01 | 6,471,887 |
2022-09-01 | Tocio Mary Ann | Option Ex | 6,602 | .00 | 0 |
2022-08-15 | Agarwal Vikas (Chief Accounting Officer) | Sale | 394 | 17.14 | 6,753 |
2022-08-15 | Agarwal Vikas (Chief Accounting Officer) | Option Ex | 1,080 | .00 | 0 |
2022-06-02 | Kennedy David P | Option Ex | 4,534 | .00 | 0 |
2022-06-02 | Blumenkranz Mark S. | Option Ex | 4,534 | .00 | 0 |
2022-06-02 | Kalen Holmes | Option Ex | 4,534 | .00 | 0 |
2022-06-02 | Lewis-hall Freda C | Option Ex | 4,534 | .00 | 0 |
2022-06-02 | Auvil Paul R. Iii | Option Ex | 4,534 | .00 | 0 |
2022-06-02 | Taylor Scott C | Option Ex | 2,267 | .00 | 0 |
2022-06-02 | Dunlevie Bruce | Option Ex | 4,534 | .00 | 0 |
2022-02-15 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 1,777 | .00 | 0 |
2022-02-15 | Mango Lisa A (General Counsel and Secretary) | Sale | 1,422 | 10.26 | 14,589 |
2022-02-15 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 2,221 | .00 | 0 |
2021-12-02 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 99,748 | 4.01 | 399,989 |
2021-09-20 | Kennedy David P | Sale | 2,778 | 24.72 | 68,672 |
2021-08-18 | Kennedy David P | Sale | 2,778 | 23.40 | 64,996 |
2021-07-19 | Kennedy David P | Sale | 2,778 | 26.34 | 73,183 |
2021-06-30 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 5,551 | 5.89 | 32,695 |
2021-06-18 | Kennedy David P | Sale | 5,556 | 33.60 | 186,659 |
2021-06-02 | Kennedy David P | Sale | 2,778 | 38.00 | 105,564 |
2021-05-18 | Kennedy David P | Sale | 5,556 | 34.45 | 191,409 |
2021-04-26 | Mango Lisa A (General Counsel and Secretary) | Sale | 1,915 | 42.15 | 80,715 |
2021-04-26 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 1,915 | 11.47 | 21,965 |
2021-04-23 | Mango Lisa A (General Counsel and Secretary) | Sale | 687 | 42.01 | 28,859 |
2021-04-23 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 687 | 11.52 | 7,910 |
2021-04-22 | Mango Lisa A (General Counsel and Secretary) | Sale | 1,500 | 42.04 | 63,061 |
2021-04-22 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 1,500 | 11.56 | 17,340 |
2021-04-21 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 41.40 | 1,241,850 |
2021-04-21 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 7.96 | 238,800 |
2021-04-19 | Kennedy David P | Sale | 8,334 | 40.89 | 340,802 |
2021-04-08 | Mango Lisa A (General Counsel and Secretary) | Sale | 1,098 | 42.03 | 46,152 |
2021-04-08 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 1,098 | 11.47 | 12,594 |
2021-04-07 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 40.46 | 1,213,860 |
2021-04-07 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.36 | 130,800 |
2021-04-05 | Mango Lisa A (General Counsel and Secretary) | Sale | 8,336 | 40.76 | 339,758 |
2021-04-05 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 8,336 | 7.77 | 64,770 |
2021-04-01 | Mango Lisa A (General Counsel and Secretary) | Sale | 3,004 | 42.05 | 126,303 |
2021-04-01 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 3,004 | 11.52 | 34,591 |
2021-03-18 | Kennedy David P | Sale | 8,334 | 40.39 | 336,626 |
2021-03-17 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 41.80 | 1,253,850 |
2021-03-17 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.36 | 130,800 |
2021-03-05 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 41,066 | 6.13 | 251,652 |
2021-03-03 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 45.12 | 1,353,510 |
2021-03-03 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.36 | 130,800 |
2021-03-03 | Mango Lisa A (General Counsel and Secretary) | Sale | 8,332 | 45.32 | 377,581 |
2021-03-03 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 8,332 | 7.77 | 64,739 |
2021-02-22 | Mango Lisa A (General Counsel and Secretary) | Sale | 4,102 | 55.72 | 228,579 |
2021-02-22 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 4,102 | 11.52 | 47,234 |
2021-02-18 | Kennedy David P | Sale | 8,334 | 55.11 | 459,320 |
2021-02-17 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 55.85 | 1,675,500 |
2021-02-17 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.36 | 130,800 |
2021-02-03 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 54.41 | 1,632,270 |
2021-02-03 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.36 | 130,800 |
2021-02-03 | Mango Lisa A (General Counsel and Secretary) | Sale | 8,332 | 54.03 | 450,186 |
2021-02-03 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 8,332 | 5.89 | 49,075 |
2021-02-01 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 12,610 | 7.93 | 99,997 |
2021-01-21 | Mango Lisa A (General Counsel and Secretary) | Sale | 4,102 | 49.98 | 205,017 |
2021-01-21 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 4,102 | 11.52 | 47,234 |
2021-01-20 | Thaler Bjorn B (Chief Financial Officer) | Sale | 20,200 | 52.50 | 1,060,500 |
2021-01-20 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 20,200 | 7.93 | 160,186 |
2021-01-20 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 52.20 | 1,566,120 |
2021-01-20 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.37 | 130,950 |
2021-01-19 | Diamond Andrew S (Chief Medical Officer) | Sale | 75,000 | 44.12 | 3,309,075 |
2021-01-19 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 75,000 | 6.43 | 482,250 |
2021-01-19 | Kennedy David P | Sale | 8,334 | 45.68 | 380,722 |
2021-01-15 | Thaler Bjorn B (Chief Financial Officer) | Sale | 20,200 | 42.57 | 859,974 |
2021-01-15 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 20,200 | 7.93 | 160,186 |
2021-01-14 | Diamond Andrew S (Chief Medical Officer) | Sale | 24,375 | 41.20 | 1,004,347 |
2021-01-14 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 24,375 | 4.36 | 106,275 |
2021-01-14 | Mango Lisa A (General Counsel and Secretary) | Sale | 58,326 | 41.43 | 2,416,504 |
2021-01-14 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 58,326 | 11.52 | 671,623 |
2021-01-12 | Rubin Amir Dan (Chair, CEO and President) | Sale | 185,457 | 41.23 | 7,646,206 |
2021-01-12 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 185,457 | 4.01 | 743,682 |
2021-01-12 | Kalen Holmes | Sale | 31,915 | 41.22 | 1,315,663 |
2021-01-11 | Rubin Amir Dan (Chair, CEO and President) | Sale | 255,000 | 41.85 | 10,672,260 |
2021-01-11 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 255,000 | 4.01 | 1,022,550 |
2021-01-08 | Rubin Amir Dan (Chair, CEO and President) | Sale | 156,545 | 42.88 | 6,713,119 |
2021-01-08 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 156,545 | 4.01 | 627,745 |
2021-01-07 | Rubin Amir Dan (Chair, CEO and President) | Sale | 165,554 | 42.72 | 7,073,129 |
2021-01-07 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 165,554 | 4.01 | 663,871 |
2021-01-06 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 43.14 | 1,294,080 |
2021-01-06 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.37 | 131,100 |
2021-01-06 | Rubin Amir Dan (Chair, CEO and President) | Sale | 208,572 | 43.15 | 8,999,047 |
2021-01-06 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 208,572 | 4.01 | 836,373 |
2021-01-05 | Rubin Amir Dan (Chair, CEO and President) | Sale | 60,867 | 43.15 | 2,626,167 |
2021-01-05 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 60,867 | 4.01 | 244,076 |
2021-01-04 | Rubin Amir Dan (Chair, CEO and President) | Sale | 68,005 | 43.09 | 2,930,539 |
2021-01-04 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 68,005 | 4.01 | 272,700 |
2020-12-28 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 43,035 | 3.52 | 151,698 |
2020-12-22 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 12,610 | 7.93 | 99,997 |
2020-12-18 | Thaler Bjorn B (Chief Financial Officer) | Sale | 40,500 | 40.12 | 1,624,657 |
2020-12-18 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 40,500 | 7.93 | 321,165 |
2020-12-18 | Kennedy David P | Sale | 8,334 | 40.02 | 333,551 |
2020-12-16 | Lockhart Kimber D (Chief Technology Officer) | Sale | 30,000 | 38.16 | 1,144,860 |
2020-12-16 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 30,000 | 4.37 | 131,100 |
2020-12-10 | Kennedy David P | Sale | 2,778 | 38.04 | 105,675 |
2020-12-09 | Kennedy David P | Sale | 2,778 | 38.00 | 105,564 |
2020-12-08 | Thaler Bjorn B (Chief Financial Officer) | Sale | 20,200 | 37.32 | 753,884 |
2020-12-08 | Thaler Bjorn B (Chief Financial Officer) | Option Ex | 20,200 | 7.93 | 160,186 |
2020-12-03 | Lockhart Kimber D (Chief Technology Officer) | Sale | 11,800 | 35.15 | 414,758 |
2020-12-03 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 11,800 | 4.37 | 51,566 |
2020-12-02 | Lockhart Kimber D (Chief Technology Officer) | Sale | 18,200 | 34.58 | 629,337 |
2020-12-02 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 18,200 | 4.37 | 79,534 |
2020-11-23 | Carlyle Partners Vii Holdings, L.p. (10% Owner) | Sale | 7,000,000 | 33.30 | 233,099,999 |
2020-11-20 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 35.00 | 525,000 |
2020-11-20 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-11-18 | Kennedy David P | Sale | 5,556 | 33.56 | 186,437 |
2020-11-18 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 33.42 | 501,300 |
2020-11-18 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-11-11 | Lockhart Kimber D (Chief Technology Officer) | Sale | 105,000 | 35.04 | 3,679,410 |
2020-11-11 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 105,000 | 4.37 | 458,850 |
2020-11-11 | Rubin Amir Dan (Chair, CEO and President) | Sale | 235,000 | 34.83 | 8,185,285 |
2020-11-11 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 235,000 | 4.01 | 942,350 |
2020-11-09 | Mango Lisa A (General Counsel and Secretary) | Sale | 13,000 | 32.57 | 423,358 |
2020-11-09 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 13,000 | 5.10 | 66,300 |
2020-11-04 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 30.48 | 457,155 |
2020-11-04 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-10-29 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 37,500 | 5.10 | 191,250 |
2020-10-22 | Kennedy David P | Sale | 2,778 | 32.00 | 88,896 |
2020-10-21 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 31.41 | 471,210 |
2020-10-21 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-10-19 | Kennedy David P | Sale | 2,778 | 30.55 | 84,854 |
2020-10-12 | Mango Lisa A (General Counsel and Secretary) | Sale | 21,000 | 30.36 | 637,623 |
2020-10-12 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 21,000 | 6.37 | 133,665 |
2020-10-07 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 29.04 | 435,540 |
2020-10-07 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-09-28 | Rubin Amir Dan (Chair, CEO and President) | Sale | 235,000 | 26.75 | 6,286,955 |
2020-09-28 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 235,000 | 4.01 | 942,350 |
2020-09-16 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 29.44 | 441,570 |
2020-09-16 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-09-02 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 29.73 | 445,905 |
2020-09-02 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-09-01 | Diamond Andrew S (Chief Medical Officer) | Sale | 62,922 | 30.01 | 1,888,352 |
2020-09-01 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 62,922 | 4.37 | 274,654 |
2020-09-01 | Mango Lisa A (General Counsel and Secretary) | Sale | 33,300 | 30.01 | 999,233 |
2020-09-01 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 33,300 | 7.16 | 238,261 |
2020-08-31 | Kennedy David P | Sale | 16,667 | 29.24 | 487,359 |
2020-08-28 | Kennedy David P | Sale | 16,667 | 29.08 | 484,609 |
2020-08-27 | Kennedy David P | Sale | 16,666 | 28.98 | 483,030 |
2020-08-27 | Rubin Amir Dan (Chair, CEO and President) | Sale | 86,611 | 29.04 | 2,514,923 |
2020-08-27 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 86,611 | 4.01 | 347,310 |
2020-08-24 | Diamond Andrew S (Chief Medical Officer) | Sale | 15,677 | 29.99 | 470,200 |
2020-08-24 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 15,677 | 4.37 | 68,508 |
2020-08-24 | Mango Lisa A (General Counsel and Secretary) | Sale | 6,700 | 30.00 | 201,013 |
2020-08-24 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 6,700 | 7.77 | 52,059 |
2020-08-24 | Rubin Amir Dan (Chair, CEO and President) | Sale | 111,135 | 29.55 | 3,283,705 |
2020-08-24 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 111,135 | 4.01 | 445,651 |
2020-08-21 | Rubin Amir Dan (Chair, CEO and President) | Sale | 155,810 | 29.27 | 4,561,337 |
2020-08-21 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 155,810 | 4.01 | 624,798 |
2020-08-20 | Diamond Andrew S (Chief Medical Officer) | Sale | 14,900 | 30.00 | 446,940 |
2020-08-20 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 14,900 | 4.43 | 66,007 |
2020-08-20 | Mango Lisa A (General Counsel and Secretary) | Sale | 8,800 | 30.00 | 264,026 |
2020-08-20 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 8,800 | 7.77 | 68,376 |
2020-08-20 | Rubin Amir Dan (Chair, CEO and President) | Sale | 140,597 | 29.77 | 4,185,853 |
2020-08-20 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 140,597 | 4.01 | 563,793 |
2020-08-19 | Diamond Andrew S (Chief Medical Officer) | Sale | 16,501 | 29.99 | 494,930 |
2020-08-19 | Diamond Andrew S (Chief Medical Officer) | Option Ex | 16,501 | 4.49 | 74,089 |
2020-08-19 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 29.63 | 444,450 |
2020-08-19 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-08-19 | Mango Lisa A (General Counsel and Secretary) | Sale | 1,200 | 30.00 | 36,003 |
2020-08-19 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 1,200 | 7.77 | 9,324 |
2020-08-19 | Rubin Amir Dan (Chair, CEO and President) | Sale | 145,414 | 29.82 | 4,336,972 |
2020-08-19 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 145,414 | 4.01 | 583,110 |
2020-08-18 | Rubin Amir Dan (Chair, CEO and President) | Sale | 33,277 | 29.08 | 967,828 |
2020-08-18 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 33,277 | 4.01 | 133,440 |
2020-08-17 | Lockhart Kimber D (Chief Technology Officer) | Sale | 15,000 | 28.31 | 424,635 |
2020-08-17 | Lockhart Kimber D (Chief Technology Officer) | Option Ex | 15,000 | 4.37 | 65,550 |
2020-08-17 | Mango Lisa A (General Counsel and Secretary) | Sale | 21,000 | 28.34 | 595,119 |
2020-08-17 | Mango Lisa A (General Counsel and Secretary) | Option Ex | 21,000 | 7.77 | 163,170 |
2020-08-17 | Rubin Amir Dan (Chair, CEO and President) | Sale | 267,156 | 28.56 | 7,630,242 |
2020-08-17 | Rubin Amir Dan (Chair, CEO and President) | Option Ex | 267,156 | 4.01 | 1,071,295 |
2020-06-29 | Carlyle Partners Vii Holdings, L.p. (10% Owner) | Sale | 7,545,000 | 29.76 | 224,539,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of ONEM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of 1life Healthcare Inc (symbol ONEM, CIK number 1404123) see the Securities and Exchange Commission (SEC) website.